1224 Tregs constrain CD8 + T cell priming required for curative intratumorally anchored anti-4–1BB immunotherapy

Documenti analoghi

• 1224 Tregs constrain CD8 + T cell priming required for curative intratumorally anchored anti-4–1BB immunotherapy
  di: Emi A Lutz, et al.
  Pubblicazione: (2023-11-01)
• An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy
  di: Sarah C. Cowles, et al.
  Pubblicazione: (2022-12-01)
• Intratumoral aluminum hydroxide–anchored IL-12 drives potent antitumor activity by remodeling the tumor microenvironment
  di: Sailaja Battula, et al.
  Pubblicazione: (2023-12-01)
• Maximizing response to intratumoral immunotherapy in mice by tuning local retention
  di: Noor Momin, et al.
  Pubblicazione: (2022-01-01)
• Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
  di: Meenu Sharma, et al.
  Pubblicazione: (2020-01-01)